MET and non-small cell lung carcinoma: Therefore, it is important and necessary to clarify the underlying molecular mechanisms of MET amplification-mediated resistance, and to find out appropriate ways to identify MET copy number gains and amplifications, so that researchers can develop effective therapeutic strategies to overcome this resistance and prolong the life of NSCLC patients.